DIR fee relief urgency clear at NACDS board member D.C. fly-in

Print Friendly, PDF & Email

NACDS Board members travelled to Washington, D.C., this week to meet with key members of Congress about the urgency of DIR fee relief. (Front row, left to right) Richard Ashworth, president, operations at Walgreen, Co.; Lynne Fruth, president and chairman of the Board, Fruth Pharmacy; Lori Flees, SVP and DMM Health and Wellness, Sam’s Club (Walmart Inc.); (second row, left to right) Craig Painter, executive chairman of the Board, Kinney Drugs, Inc.; NACDS Chairman Chris Lane, RPh, executive vice president, Wakefern Food Corp./ShopRite; Rick Keyes, president and CEO, Meijer, Inc.; (back row, left to right) Randy Edeker, chairman, CEO and president, Hy-Vee, Inc.; Steven Anderson, NACDS president and CEO; Kevin Hourican, president, CVS Pharmacy and executive vice president, CVS Health; and Kirk Kaminsky, president, Pharmaceutical Solutions and Services, McKesson, representing Health Mart.

WASHINGTON — Ten NACDS board of directors members met with key members of Congress in Washington, D.C. this week. The meetings focused on conveying the urgent need for direct and indirect remuneration (DIR) fee relief.

The timing was ideal, given that decisions are being made now about drug-pricing legislation.



Comments are closed.